What is Precigen's D&A?

Precigen (PGEN) reported D&A of $1.1M in Q1 2026.

How has Precigen's D&A changed year-over-year?

Precigen's D&A increased by 74.7% year-over-year, from $629K to $1.1M.

What is the long-term trend for Precigen's D&A?

Over 4 years (2021 to 2025), Precigen's D&A has grown at a -30.6% compound annual growth rate (CAGR), from $13.76M to $3.2M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

Precigen PGEN D&A

D&A at other companies

Bristol-Myers SquibbBMY

$594M-41.3%

Regeneron PharmaceuticalsREGN

$123.2M-2.9%

Viridian Therapeutics, Inc.VRDN

$121K+3.4%

Agios PharmaceuticalsAGIO

$1.36M+6.7%

Apogee Therapeutics, Inc.APGE

$408K+97.1%

Arrowhead ResearchARWR

$6.37M+4.7%

Other financials

Income statement

See full

Revenue$23.3M+1,634%

Operating income-$6.0M+73.5%

Net income-$7.9M+85.4%

EPS (diluted)-$0.02+88.9%

Balance sheet

See full

Cash & equivalents$7.5M+23.5%

Total debt$98.3M+1,714%

Total equity$20.2M+244%

Total assets$138.6M+7.6%

Cash flow

See full

Operating cash flow-$43.8M-168%

CapEx$258.0K-58.5%

Free cash flow-$44.1M-160%

Valuation

See full

Market cap$1.91B+213%

Enterprise value$2B+234%

P/S72×—

Profitability

See full

Gross margin83.6%—

Operating margin-2,890.9%—

Net margin-3,656%—

FCF margin-1,756.5%—

Returns & leverage

See full

Return on equity-843.6%-1,103pp

Debt / equity4.9×—

Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Precigen's D&A?: Precigen (PGEN) reported D&A of $1.1M in Q1 2026.
How has Precigen's D&A changed year-over-year?: Precigen's D&A increased by 74.7% year-over-year, from $629K to $1.1M.
What is the long-term trend for Precigen's D&A?: Over 4 years (2021 to 2025), Precigen's D&A has grown at a -30.6% compound annual growth rate (CAGR), from $13.76M to $3.2M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.